Search results

NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.

Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.

This guidance evaluates digital technologies, diagnostics and medical devices (including artificial intelligence).

Biographies for all current members of the diagnostics advisory committee.

Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.

How to register with us as a diagnostic technologies stakeholder.

How to register with us as a medical technologies stakeholder.

NICE is committed to involving people who use services, carers and the public in the development of our guidance and other products.

Our recommendations on the use of highly specialised technologies are made by an independent advisory committee

Advises NICE on the formulation of its guidance on the safety and efficacy of interventional procedures.

Find out more about the NICE technology appraisal advisory committee B members and their registered interests

Biographies and registered interests for members of the Technology Appraisal Committee A

Charging procedure for NICE technology appraisal and highly specialised technologies evaluations

Learn about NICE's proportionate approach to technology appraisals, which aims to streamline the evaluation process for new health technologies, ensuring timely access to innovative treatments while maintaining rigorous standards.

The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals.